icd 9 code for erythropoietin independent erythrocytosis

What is the ICD 10 code for erythrocytosis?

Erythrocytosis (megalosplenic) (secondary) D75.1. ICD-10-CM Diagnosis Code D75.1. Secondary polycythemia. 2016 2017 2018 2019 2020 2021 Billable/Specific Code. Applicable To. Acquired polycythemia. Emotional polycythemia. Erythrocytosis NOS. Hypoxemic polycythemia.

What is idiopathic erythrocytosis?

Idiopathic erythrocytosis, diagnosis and clinical management By definition, idiopathic erythrocytosis (IE) applies to a group of patients characterised by having a measured RCM above their predicted normal range (an absolute erythrocytosis) and following investigation do not have a form of primary or secondary erythrocytosis.

What is the ICD 9 code for secondary polycythemia?

Polycythemia, secondary. Short description: Secondary polycythemia. ICD-9-CM 289.0 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 289.0 should only be used for claims with a date of service on or before September 30, 2015.

Is the erythropoietin level an accurate indicator of disease diagnosis?

The erythropoietin level provides some guidance as to the direction in which to proceed and the order and extent of investigation necessary in an individual patient. It should thus be possible to make an accurate diagnosis in the majority of patients. Publication types Review MeSH terms

What is the diagnosis code for Erythrocytosis?

D75. 0 - Familial erythrocytosis | ICD-10-CM.

What are two conditions that cause polycythemia?

Apparent polycythaemia is often caused by being overweight, smoking, drinking too much alcohol or taking certain medicines – including diuretics (tablets for high blood pressure that make you pee more). Apparent polycythaemia may improve if the underlying cause is identified and managed.

What is the diagnosis code for polycythemia?

D45 - Polycythemia vera. ICD-10-CM.

What is the ICD-10 code for secondary polycythemia?

ICD-10 code D75. 1 for Secondary polycythemia is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .

What is the difference between polycythemia and erythrocytosis?

Erythrocytosis is sometimes referred to as polycythemia, but the conditions are slightly different: Erythrocytosis is an increase in RBCs relative to the volume of blood. Polycythemiais an increase in both RBC concentration and hemoglobin, the protein in red blood cells that carries oxygen to the body's tissues.

What happens during erythrocytosis?

Erythrocytosis is when you have more red blood cells than normal. Red blood cells are also called erythrocytes. Red blood cells carry oxygen throughout your body and remove carbon dioxide from your body. Your bone marrow (the tissue inside your bones) makes red blood cells and releases them into your bloodstream.

What is the ICD 10 code for elevated HGB?

ICD-10-CM Diagnosis Code R97 R97.

What is the code for polycythemia secondary to living in a high altitude region?

D75. 1 - Secondary polycythemia. ICD-10-CM.

What is the ICD 10 code for PCV?

Primary – Polycythemia Vera [PCV] – Polycythemia Rubra Vera [PRV] – Erythremia (ICD-10: D45)

What is secondary Erythrocytosis?

Secondary polycythemia, also known as secondary erythrocytosis or secondary erythrocythemia, is a rare condition in which your body produces an excess amount of red blood cells. This overproduction of red blood cells thickens your blood.

What is the ICD-10 code for unspecified polycythemia?

D45 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D45 became effective on October 1, 2021.

What is familial erythrocytosis?

Familial erythrocytosis is an inherited condition characterized by an increased number of red blood cells (erythrocytes). The primary function of these cells is to carry oxygen from the lungs to tissues and organs throughout the body.

What are the two types of polycythemia?

There are two types of polycythemia, which have different causes.Primary polycythemia. Primary polycythemia is also called polycythemia vera (PV). ... Secondary polycythemia. Secondary polycythemia can occur if the increase in red blood cells is not due to the myeloproliferative disease of PV. ... Risk factors.

What is polycythemia and what are its causes?

Overview. Polycythemia vera (pol-e-sy-THEE-me-uh VEER-uh) is a type of blood cancer. It causes your bone marrow to make too many red blood cells. These excess cells thicken your blood, slowing its flow, which may cause serious problems, such as blood clots. Polycythemia vera is rare.

What is the most common cause of secondary polycythemia?

Secondary polycythemia most often develops as a response to chronic hypoxemia, which triggers increased production of erythropoietin by the kidneys. The most common causes of secondary polycythemia include obstructive sleep apnea, obesity hypoventilation syndrome, and chronic obstructive pulmonary disease (COPD).

What are the causes of high red blood cell count?

CausesHeart disease (such as congenital heart disease in adults)Heart failure.A condition present at birth that reduces the oxygen-carrying capacity of red blood cells (hemoglobinopathy)High altitudes.COPD (chronic obstructive pulmonary disease) exacerbation — worsening of symptoms.More items...

What is D50-D89?

D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

When will the ICd 10 D75.0 be released?

The 2022 edition of ICD-10-CM D75.0 became effective on October 1, 2021.

What is erythropoietin assay?

This test is intended as an aid in the diagnosis of anemias and polycythemias. With the advent of the administration of recombinant erythropoietin as a biologic therapy to increase red blood cell mass, an erythropoietin assay may be used also to aid in the prediction and monitoring of response to recombinant erythropoietin treatment of anemia.

Why is erythropoietin used in rhepo?

12,15 rhEPO is used by some athletes as a performance enhancing drug in an effort to increase endurance and oxygen capacity by increasing the red blood cell count. 16 This inappropriate use of the drug can result in adverse clinical consequences due to hypertension and increased blood viscosity. Its use has been prohibited by most sports organizations.

What is EPO in kidney disease?

EPO levels are often measured in patients with chronic kidney disease to assess the kidneys' continued ability to produce erythropoietin. Anemias of chronic disease (chronic infections, autoimmune diseases, rheumatoid arthritis, AIDS, malignancies), are characterized by a blunted response of erythroid progenitors to EPO.

What is a recombinant human EPO?

Recombinant human EPO (rhEPO) is administered clinically to stimulate red cell production in patients with chronic kidney disease, HIV-infected patients treated with zidovudine, patients undergoing myelosuppressive chemotherapy treatment, and other anemic patients (as an alternative to blood transfusion.) 13,14 Several investigators have reported that in chemotherapy-treated cancer patients, baseline EPO levels of greater than 500 mIU/mL predicts unresponsiveness to EPO therapy. Endogenous serum erythropoietin levels are measured as a qualification criterion for rhEPO treatment of anemia in HIV-infected patients taking zidovudine. 13

What is the role of EPO in the blood?

Erythropoietin (EPO), a glycoprotein (~30,400 daltons) produced primarily by the kidney, is the principal factor regulating red blood cell production (erythropoiesis) in mammals. 3 Renal production is regulated by changes in oxygen availability. Normally, EPO levels vary inversely with hematocrit. Under conditions of hypoxia, the level of EPO in the circulation increases, leading to increased production of red blood cells. Conversely, a high hematocrit should suppress the release of EPO.

What are the causes of low EPO levels?

Lower EPO levels than expected have been seen in anemias associated with the following: rheumatoid arthritis, acquired immunodeficiency syndrome, cancer, ulcerative colitis, sickle cell disease, and in premature neonates. 1.

Can you perform an EPO test on the same patient?

Because results obtained with one commercial EPO assay may differ significantly from those obtained with another, it is recommended that serial testing performed on the same patient over time should be performed with the same commercial EPO test. 1

What is idiopathic erythrocytosis?

By definition, idiopathic erythrocytosis (IE) applies to a group of patients characterised by having a measured RCM above their predicted normal range (an absolute erythrocytosis) and following investigation do not have a form of primary or secondary erythrocytosis. Patients with IE are heterogenous. The possibilities include physiological variation, 'early' polycythaemia vera (10-15% develop clear features of PV over a few years), unrecognized congenital erythrocytosis, unrecognized or unrecognizable secondary acquired erythrocytosis or a currently undescribed form of primary or secondary erythrocytosis. Patients are more commonly male with a median age at presentation of 55-60 years. Approximately half of the patients present with vascular occlusive complications. Retrospective evidence indicates that vascular occlusion occurs less frequently when the PCV is controlled at normal levels. Venesection is the treatment of choice to lower the PCV. As a general approach to management, all patients with a PCV above 0.54 should be venesected to a PCV less than 0.45. This target PCV should also apply to patients with lesser degrees of raised PCV who have additional other risk factors for vascular occlusion.

What is IE in medical terms?

By definition, idiopathic erythrocytosis (IE) applies to a group of patients characterised by having a measured RCM above their predicted normal range (an absolute erythrocytosis) and following investigation do not have a form of primary or secondary erythrocytosis. Patients with IE are heterogenous …

Test Code

Ordering Restrictions may apply. Please provide SERVICE AREA INFORMATION to find available tests you can order.

Clinical Significance

Erythropoietin - Elevated levels of serum erythropoietin (EPO) occur in patients with anemias due to increased red cell destruction in hemolytic anemia and also in secondary polycythemias associated with impaired oxygen delivery to the tissues, impaired pulmonary oxygen exchange, abnormal hemoglobins with increased oxygen affinity, constriction of the renal vasculature, and inappropriate EPO secretion caused by certain renal and extrarenal tumors.

Test Details

Due to diurnal variation, it is recommended that specimens be collected between 7: 30am and noon